Ladera Ranch, California
United States
56
2025-01-16
The entities that hold a legal rights for patent applications filed by inventor Sinha Santosh C.:
Santosh C. Sinha from Ladera Ranch, US has applied for patents for these inventions. The list has both pending applications and granted patents:
PHARMACOLOGICAL AGENTS FOR TREATING OPHTHALMIC DISEASES
#2 | 2024-10-03PHARMACOLOGICAL AGENTS FOR PREVENTING AND TREATING CATARACTS AND PRESBYOPIA EYE DISEASES
#3 | 2023-03-02METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#4 | 2020-10-22METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#5 | 2018-12-06METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#6 | 2018-03-15METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#7 | 2017-06-22Methods of treating Ī± adrenergic mediated conditions
#8 | 2016-02-18N-(IMIDAZOLIDIN-2-YLIDENE)QUINOLINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
#9 | 2015-08-13Methods of treating Ī± adrenergic mediated conditions
#10 | 2015-07-30Alpha adrenergic receptor modulators
#11 | 2014-11-06Nā(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
#12 | 2014-09-11Steroid conjugates
#13 | 2014-09-11STEROID ANTIBIOTIC CONJUGATES
#14 | 2014-09-11ANTIBIOTIC CONJUGATES WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
#15 | 2014-09-11ANTIBIOTIC CONJUGATES LINKED WITH STEROID DRUGS
#16 | 2014-09-11Antibiotic Conjugates
#17 | 2014-09-11Cyclosporine A steroid conjugates
#18 | 2014-09-11Antibiotic conjugates directly linked with steroid drugs
#19 | 2014-08-14-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
#20 | 2014-07-24SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF
#21 | 2013-12-19NOVEL INDOLE MODULATORS OF S1P RECEPTORS
#22 | 2013-12-05N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
#23 | 2013-11-21Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#24 | 2013-08-22Therapeutic compounds
#25 | 2013-06-13Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
#26 | 2013-01-31N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors
#27 | 2013-01-31N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
#28 | 2012-12-06Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
#29 | 2012-08-23Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
#30 | 2012-08-16Alpha adrenergic receptor modulators
#31 | 2012-08-09SUBSTITUTED-ARYL-(IMIDAZOLE)-METHYL)-PHENYL COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA 2B AND/OR ALPHA 2C ADRENERGIC RECEPTORS
#32 | 2012-06-28Methods of treating alpha adrenergic mediated conditions
#33 | 2012-06-07Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
#34 | 2012-06-07Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
#35 | 2012-05-24Modulators of S1P receptors
#36 | 2012-05-24Indole modulators of S1P receptors
#37 | 2012-02-09METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
#38 | 2011-12-15PYRIDINE COMPOUNDS AS SUBTYPE SELECTIVE MODULATORS OF ALPHA2B AND /OR ALPHA 2C ADRENERGIC RECEPTORS
#39 | 2011-09-29Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
#40 | 2011-07-21Therapeutic compounds
#41 | 2011-05-05Selective subtype alpha 2 adrenergic agents and methods for use thereof
#42 | 2011-04-28Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
#43 | 2011-03-31Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
#44 | 2011-02-17Therapeutic compounds
#45 | 2011-02-10Selective subtype alpha 2 adrenergic agents and methods for use thereof
#46 | 2011-02-03Selective alpha 2B/2C agonists
#47 | 2010-10-28((PHENYL)IMIDAZOLYL)METHYLHETEROARYL COMPOUNDS
#48 | 2010-08-05Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
#49 | 2010-07-29Therapeutic ((bicylicheteroaryl)imidazolyl) methylheteroaryl compounds
#50 | 2010-06-10N-(1-phenyl-2-arylethyl)-4,5-dihydro-2H-pyrrol-5-amine compounds as subtype selective modulators of ALPHA2B or ALPHA2B and ALPHA2C adrenoceptors
#51 | 2010-01-14THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
#52 | 2009-12-10Methods of treating alpha adrenergic mediated conditions
#53 | 2009-12-10Methods of treating alpha adrenergic mediated conditions
#54 | 2009-11-12THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDS
#55 | 2009-07-16ALPHA 2 ADRENERGIC AGONISTS
#56 | 2009-07-09Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
68532 ā